As mentioned above, this is in contrast to a recent study which showed LTβR agonist treatment alone to be sufficient in inducing TA-HEVs which were associated with the presence of T and B cells as well as a reduction in tumor weight (28). This evidence concerns the gene LTBR and neoplasm.